These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 580375)

  • 21. Complexation of cytochrome P-450 isozymes in hepatic microsomes from SKF 525-A-induced rats.
    Murray M
    Arch Biochem Biophys; 1988 May; 262(2):381-8. PubMed ID: 3364973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro metabolism of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, a water-soluble antitumor nitrosourea.
    Nishigaki T; Nakamura K; Tanaka M
    J Pharmacobiodyn; 1985 Jun; 8(6):409-16. PubMed ID: 3863922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catabolism of pentachlorophenol by a Flavobacterium sp.
    Steiert JG; Crawford RL
    Biochem Biophys Res Commun; 1986 Dec; 141(2):825-30. PubMed ID: 3801030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol metabolism: role of microsomal oxidation in vivo.
    Tephly TR; Tinelli F; Watkins WD
    Science; 1969 Oct; 166(3905):627-8. PubMed ID: 5823298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of pentachlorophenol to tetrachlorohydroquinone by human liver homogenate.
    Juhl U; Witte I; Butte W
    Bull Environ Contam Toxicol; 1985 Nov; 35(5):596-601. PubMed ID: 4074922
    [No Abstract]   [Full Text] [Related]  

  • 26. Microsomal metabolism of the carcinogen, N-2-fluorenylacetamide, by the mammary gland and liver of female rats. I. Ring- and N-hydroxylations of N-2-fluorenylacetamide.
    Malejka-Giganti D; Decker RW; Ritter CL; Polovina MR
    Carcinogenesis; 1985 Jan; 6(1):95-103. PubMed ID: 3967341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation.
    Buckpitt AR; Bahnson LS; Franklin RB
    J Pharmacol Exp Ther; 1984 Nov; 231(2):291-300. PubMed ID: 6491983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of 2,4-dichloro-6-phenoxyethyl-amine (DPEA) and -diethylaminoethyl diphenylpropylacetate (SKF-525A) on hepatic microsomal azoreductase activity from phenobarbital or 3-methylcholanthrene induced rats.
    Shargel L; Mazel P
    Biochem Pharmacol; 1972 Jan; 21(1):69-75. PubMed ID: 4400525
    [No Abstract]   [Full Text] [Related]  

  • 29. Interaction of parathion and malathion with hepatic cytochrome P-450 from rats treated with phenobarbital and carbon disulfide.
    Dalvi RR; Howell CD
    Drug Chem Toxicol; 1978; 1(2):191-202. PubMed ID: 755667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of phenobarbital, dexamethasone, and 3-methylcholanthrene administration on the metabolism of 17 beta-estradiol by liver microsomes from female rats.
    Suchar LA; Chang RL; Thomas PE; Rosen RT; Lech J; Conney AH
    Endocrinology; 1996 Feb; 137(2):663-76. PubMed ID: 8593816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of phenobarbital and beta-naphthoflavone on the in vivo toxicity and in vitro metabolism of aflatoxin in an aflatoxin-resistant and control line of chickens.
    Manning RO; Wyatt RD; Marks HL
    J Toxicol Environ Health; 1990 Dec; 31(4):291-311. PubMed ID: 2123938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SKF 525-A inhibition, induction, and 452-nm complex formation.
    Buening MK; Franklin MR
    Drug Metab Dispos; 1976; 4(3):244-55. PubMed ID: 6229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of phenobarbital and SKF-525A on in vitro hepatic metabolism of verapamil and nifedipine.
    Hamann SR; Tan TG; Kaltenborn KE; Brouwer KL; Blouin RA; Chang SL; Vore M; McAllister RG
    Pharmacology; 1985; 30(3):121-8. PubMed ID: 3975261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Qualitative and quantitative differences in the induction and inhibition of hepatic benzo[a]pyrene metabolism in the rat and hamster.
    Wroblewski VJ; Gessner T; Olson JR
    Biochem Pharmacol; 1988 Apr; 37(8):1509-17. PubMed ID: 3358781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixed-function oxidase system induction and propylene hepatotoxicity.
    Osimitz TG; Conolly RB
    J Toxicol Environ Health; 1985; 15(1):39-49. PubMed ID: 2984438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of phenobarbital upon triacylglycerol metabolism in the rabbit.
    Goldberg DM; Roomi MW; Yu A; Roncari DA
    Biochem J; 1980 Oct; 192(1):165-75. PubMed ID: 7305894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the effects of pretreatment with phenobarbitone and 3-methylcholanthrene on the metabolism of aflatoxin B1 by rat liver microsomes and isolated hepatocytes in vitro.
    Metcalfe SA; Colley PJ; Neal GE
    Chem Biol Interact; 1981 May; 35(2):145-57. PubMed ID: 6783328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triacylglycerol metabolism in the phenobarbital-treated rat.
    Goldberg DM; Roomi MW; Yu A; Roncari DA
    Biochem J; 1981 Apr; 196(1):337-46. PubMed ID: 7306075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of dihalomethanes to carbon monoxide. II. In vitro studies.
    Kubic VL; Anders MW
    Drug Metab Dispos; 1975; 3(2):104-12. PubMed ID: 236156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor in rat: relationship of metabolism to MAO-B inhibitory potency.
    Yoshida T; Yamada Y; Yamamoto T; Kuroiwa Y
    Xenobiotica; 1986 Feb; 16(2):129-36. PubMed ID: 3083608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.